Five-Year Outcomes of Primary Hip Arthroscopy for Femoroacetabular Impingement Syndrome Among Female Patients: Higher Body Mass Index Is Associated With Reduced Clinically Significant Outcomes

医学 髋关节镜检查 体质指数 股骨髋臼撞击 最小临床重要差异 外科 回顾性队列研究 逻辑回归 曼惠特尼U检验 生存曲线 关节镜检查 内科学 随机对照试验 癌症
作者
Dhruv S. Shankar,Andrew S. Bi,Michael Buldo‐Licciardi,Nicole D. Rynecki,Berkcan Akpinar,Thomas Youm
出处
期刊:Arthroscopy [Elsevier BV]
卷期号:40 (3): 732-741 被引量:12
标识
DOI:10.1016/j.arthro.2023.06.035
摘要

To evaluate the impact of age, body mass index (BMI), and symptom duration on 5-year clinical outcomes among females following primary hip arthroscopy for femoroacetabular impingement syndrome (FAIS).We conducted a retrospective review of a prospectively collected database of hip arthroscopy patients with a minimum 5-year follow-up. Patients were stratified by age (<30, 30-45, ≥45 years), BMI (<25.0, 25.0-29.9, ≥30.0), and preoperative symptom duration (<1 vs ≥1 year). Patient-reported outcomes were assessed using the modified Harris Hip Score (mHHS) and Non-Arthritic Hip Score (NAHS). Pre- to postoperative improvement in mHHS and NAHS was compared between groups using the Mann-Whitney U test or Kruskal-Wallis test. Hip survivorship rates and minimum clinically important difference (MCID) achievement rates were compared with Fisher exact test. Predictors of outcomes were identified using multivariable linear and logistic regression. P values <.05 were considered significant.In total, 103 patients were included in the analysis with a mean age of 42.0 ± 12.6 years (range, 16-75) and mean BMI of 24.9 ± 4.8 (range, 17.2-38.9). Most patients had symptoms of duration ≥1 year (60.2%). Six patients (5.8%) had arthroscopic revisions, and 2 patients (1.9%) converted to total hip arthroplasty by 5-year follow-up. Patients with BMI ≥30.0 had significantly lower postoperative mHHS (P = .03) and NAHS (P = .04) than those with BMI <25.0. Higher BMI was associated with reduced improvement in mHHS (β = -1.14, P = .02) and NAHS (β = -1.34, P < .001) and lower odds of achieving the mHHS MCID (odds ratio [OR] = 0.82, P = .02) and NAHS MCID (OR = 0.88, P = .04). Older age was predictive of reduced improvement in NAHS (β = -0.31, P = .046). Symptom duration ≥1 year was predictive of higher odds of achieving the NAHS MCID (OR = 3.98, P = .02).Female patients across a wide range of ages, BMIs, and symptom durations experience satisfactory 5-year outcomes following primary hip arthroscopy, but higher BMI is associated with reduced improvement in patient-reported outcomes.Level III, retrospective comparative prognostic trial.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
冷面发布了新的文献求助10
2秒前
3秒前
4秒前
Re发布了新的文献求助10
4秒前
lll发布了新的文献求助10
4秒前
科研通AI5应助段以柳采纳,获得10
5秒前
5秒前
6秒前
6秒前
newwen发布了新的文献求助10
7秒前
17ayyy发布了新的文献求助10
7秒前
研友_ZGRvon发布了新的文献求助10
8秒前
积极的若山完成签到,获得积分10
9秒前
天真的之柔完成签到,获得积分20
9秒前
彭于晏应助周杰伦啦啦采纳,获得10
9秒前
细心寒凡发布了新的文献求助10
10秒前
酷波er应助侯悦茹采纳,获得30
11秒前
Doctor_wan89发布了新的文献求助10
12秒前
12秒前
科研通AI5应助小闫同学采纳,获得10
12秒前
13秒前
英俊的铭应助pokexuejiao采纳,获得30
13秒前
小马甲应助这小猪真帅采纳,获得10
13秒前
无花果应助诚心的焱采纳,获得10
13秒前
13秒前
13秒前
灵犀完成签到 ,获得积分10
15秒前
完美世界应助细心寒凡采纳,获得10
17秒前
研友_ZGRvon完成签到,获得积分0
18秒前
18秒前
害羞的小刺猬完成签到,获得积分10
19秒前
光亮青柏发布了新的文献求助20
19秒前
19秒前
科研民工完成签到,获得积分10
19秒前
Doctor_wan89完成签到,获得积分10
19秒前
binxman完成签到,获得积分10
20秒前
充电宝应助xin采纳,获得10
20秒前
小蘑菇应助lll采纳,获得10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Zeolites: From Fundamentals to Emerging Applications 1500
Architectural Corrosion and Critical Infrastructure 1000
Early Devonian echinoderms from Victoria (Rhombifera, Blastoidea and Ophiocistioidea) 1000
Hidden Generalizations Phonological Opacity in Optimality Theory 1000
Handbook of Social and Emotional Learning, Second Edition 900
2026国自然单细胞多组学大红书申报宝典 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4916646
求助须知:如何正确求助?哪些是违规求助? 4190063
关于积分的说明 13013239
捐赠科研通 3959493
什么是DOI,文献DOI怎么找? 2170751
邀请新用户注册赠送积分活动 1188815
关于科研通互助平台的介绍 1096866